| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |